As of March 23, 2026, Pyxis Oncology's top three insider holders are Lara Sullivan (President And Ceo, 2.40Mn shares), Pamela Ann Connealy (Cfo Coo, 1.20Mn shares), Asset Management, Lp Cormorant (Other, 1.12Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Lara Sullivan | President And Ceo | 2,403,882 | 0 | 18 Sep, 2023 |
| Pamela Ann Connealy | Cfo Coo | 0 | 1,199,143 | 27 Nov, 2024 |
| Asset Management, Lp Cormorant | 0 | 1,118,854 | 15 Oct, 2021 | |
| Pamela Ann Connealy | Cfo Coo | 1,110,293 | 0 | 28 Mar, 2024 |
| Jay Feingold | Chief Medical Officer | 730,345 | 0 | 28 Mar, 2023 |
| Jitendra Wadhane | Svp, Chief Accounting Officer | 398,421 | 0 | 28 Mar, 2024 |
| Darren S Cline | 251,405 | 0 | 28 Mar, 2024 | |
| Thomas Civik | 206,186 | 0 | 28 Mar, 2023 | |
| Rachel Humphrey | 96,805 | 0 | 28 Mar, 2024 | |
| Mark Chin | 66,831 | 0 | 04 Apr, 2022 | |
| Jakob Dupont | 38,741 | 0 | 28 Mar, 2024 | |
| Thomas Civik | 0 | 15,700 | 19 Nov, 2021 | |
| Santhosh Palani | 6,000 | 0 | 07 Jun, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Feb, 2026 | Thomas Civik | Stock Option (Right to Buy) | A | 690,131 | $0.00 | 690,131 | D | A |
| 31 Mar, 2025 | Santhosh Palani | Stock Option (Right to Buy) | A | 36,979 | $0.98 | 36,979 | D | A |
| 31 Mar, 2025 | Jakob Dupont | Stock Option (Right to Buy) | A | 36,979 | $0.98 | 36,979 | D | A |
| 31 Mar, 2025 | Rachel Humphrey | Stock Option (Right to Buy) | A | 36,979 | $0.98 | 36,979 | D | A |
| 31 Mar, 2025 | Pamela Ann Connealy | Stock Option (Right to Buy) | A | 414,163 | $0.98 | 414,163 | D | A |
| 31 Mar, 2025 | Jitendra Wadhane | Stock Option (Right to Buy) | A | 263,782 | $0.98 | 263,782 | D | A |
| 31 Mar, 2025 | Lara Sullivan | Stock Option (Right to Buy) | A | 918,308 | $0.98 | 918,308 | D | A |
| 31 Mar, 2025 | Thomas Civik | Stock Option (Right to Buy) | A | 36,979 | $0.98 | 36,979 | D | A |
| 31 Mar, 2025 | Darren S Cline | Stock Option (Right to Buy) | A | 36,979 | $0.98 | 36,979 | D | A |
| 23 Dec, 2024 | Pamela Ann Connealy | Stock Option (Right to Buy) | A | 310,000 | $0.00 | 310,000 | D | A |
| 23 Dec, 2024 | Jitendra Wadhane | Stock Option (Right to Buy) | A | 150,000 | $0.00 | 150,000 | D | A |
| 23 Dec, 2024 | Lara Sullivan | Stock Option (Right to Buy) | A | 1,135,000 | $0.00 | 1,135,000 | D | A |
| 26 Nov, 2024 | Pamela Ann Connealy | Common Stock | A | 5,450 | $2.00 | 1,115,743 | I | P |
| 26 Nov, 2024 | Pamela Ann Connealy | Common Stock | A | 83,400 | $1.96 | 1,199,143 | I | P |
| 07 Jun, 2024 | Santhosh Palani | Common Stock | A | 6,000 | $0.00 | 6,000 | D | A |
| 26 Mar, 2024 | Pamela Ann Connealy | Common Stock | A | 328,710 | $0.00 | 1,110,293 | D | A |
| 26 Mar, 2024 | Darren S Cline | Common Stock | A | 35,219 | $0.00 | 251,405 | D | A |
| 26 Mar, 2024 | Lara Sullivan | Stock Option (Right to Buy) | A | 1,071,242 | $3.83 | 1,071,242 | D | A |
| 26 Mar, 2024 | Thomas Civik | Stock Option (Right to Buy) | A | 44,024 | $3.83 | 44,024 | D | A |
| 26 Mar, 2024 | Jakob Dupont | Common Stock | A | 38,741 | $0.00 | 38,741 | D | A |